Article
Fms like tyrosine kinase (FLT3) and nucleophosmin 1 (NPM1) mutations in de novo normal karyotype acute myeloid leukemia (AML).
Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2010
Dunna Nageswara Rao, Rajappa Senthil, Digumarti Raghunadharao, Vure Sugunakar, Kagita Sailaja, Damineni Surekha, Rao V R, Yadav Satish Kumar, Ravuri Rajasekhara Reddy, Satti Vishnupriya
Abstract excerpt
Mutations in FLT3 and NPM1 are important prognostic factors in AML, influencing outcome in normal karyotype cases. We here analysed incidences of FLT3/ITD, D 835 and NPM1 mutations in patients with de novo normal karyotype AML using PCR and gene sequencing, along with laboratory parameters and treatment outcomes. There were 128 patients with a median age of 45 years (range, 19-65). FLT3/ITD mutations were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
